Effect of rabeprazole-based triple therapy for associated gastric ulcer caused by the helicobacter pylori infection
10.3760/cma.j.issn.1008-6706.2011.03.019
- VernacularTitle:雷贝拉唑三联疗法治疗幽门螺杆菌感染相关性胃溃疡的疗效观察
- Author:
Wen LIAO
;
Ke SI
- Publication Type:Journal Article
- Keywords:
Stomach ulcer;
Helicobacter pylori;
Rabeprazole
- From:
Chinese Journal of Primary Medicine and Pharmacy
2011;18(3):325-327
- CountryChina
- Language:Chinese
-
Abstract:
Objective To evaluate the effects of rabeprazole-based triple therapy for associated gastric ulcer caused by the helicobacter pylori(Hp) infection. Methods 100 patients with associated gastric ulcer caused by the Hp infection were randomly divided into treatment group and control group. The treatment group was given rabeprazole-based triple therapy( rabeprazole 10mg bid, amoxicillin 1.0g bid and clarithromycin 500mg bid), and the control group was given omeprazole-based triple therapy( omeprazole 20mg bid, amoxicillin 1.0g bid and clarithromycin 500mg bid). The two groups were given 7 days treatment. Results The total effective rate of clinical symptoms of treatment group was 96. 0% ,the healing rate of the treatment group was 88.0%, the total effective rate of gastroscopy effect of treatment group was 94.0% ,the Hp clearance rate of treatment group was 92.0% and the Hp eradication rate of treatment group was 90. 0% ,which were higher than the control group,but the difference was not significant( P ＞ 0. 05 ). The two groups had no significant adverse reactions. Conclusion Rabeprazole-based triple therapy for associated gastric ulcer caused by the Hp infection was effective, safe and worth popularization and application.
